Cargando…

Chimeric calicivirus-like particles elicit specific immune responses in pigs

Virus-like particles (VLPs) have received considerable attention due to their potential application in veterinary vaccines and, in particular, VLPs from rabbit haemorrhagic disease virus (RHDV) have successfully shown to be good platforms for inducing immune responses against an inserted foreign epi...

Descripción completa

Detalles Bibliográficos
Autores principales: Crisci, E., Fraile, L., Moreno, N., Blanco, E., Cabezón, R., Costa, C., Mussá, T., Baratelli, M., Martinez-Orellana, P., Ganges, L., Martínez, J., Bárcena, J., Montoya, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115503/
https://www.ncbi.nlm.nih.gov/pubmed/22306796
http://dx.doi.org/10.1016/j.vaccine.2012.01.069
_version_ 1783514111615696896
author Crisci, E.
Fraile, L.
Moreno, N.
Blanco, E.
Cabezón, R.
Costa, C.
Mussá, T.
Baratelli, M.
Martinez-Orellana, P.
Ganges, L.
Martínez, J.
Bárcena, J.
Montoya, M.
author_facet Crisci, E.
Fraile, L.
Moreno, N.
Blanco, E.
Cabezón, R.
Costa, C.
Mussá, T.
Baratelli, M.
Martinez-Orellana, P.
Ganges, L.
Martínez, J.
Bárcena, J.
Montoya, M.
author_sort Crisci, E.
collection PubMed
description Virus-like particles (VLPs) have received considerable attention due to their potential application in veterinary vaccines and, in particular, VLPs from rabbit haemorrhagic disease virus (RHDV) have successfully shown to be good platforms for inducing immune responses against an inserted foreign epitope in mice. The aim of this study was to assess the immunogenicity of chimeric RHDV-VLPs as vaccine vectors in pigs. For this purpose, we have generated chimeric VLPs containing a well-known T epitope of 3A protein of foot-and-mouth disease virus (FMDV). Firstly, RHDV-VLPs were able to activate immature porcine bone marrow-derived dendritic cells (poBMDCs) in vitro. Secondly, pigs were inoculated twice in a two-week interval with chimeric RHDV-VLPs at different doses intranasally or intramuscularly. One intramuscularly treated group was also inoculated with adjuvant Montanide™ ISA 206 at the same time. Specific IgG and IgA antibodies against RHDV-VLPs were induced and such levels were higher in the adjuvanted group compared with other groups. Interestingly, anti-RHDV-VLP IgA responses were higher in groups inoculated intramuscularly than those that received the VLPs intranasally. Two weeks after the last immunisation, specific IFN-γ-secreting cells against 3A epitope and against RHDV-VLPs were detected in PBMCs by ELISPOT. The adjuvanted group exhibited the highest IFN-γ-secreting cell numbers and lymphoproliferative specific T cell responses against 3A epitope and RHDV-VLP. This is the first immunological report on the potential use of chimeric RHDV-VLPs as antigen carriers in pigs.
format Online
Article
Text
id pubmed-7115503
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71155032020-04-02 Chimeric calicivirus-like particles elicit specific immune responses in pigs Crisci, E. Fraile, L. Moreno, N. Blanco, E. Cabezón, R. Costa, C. Mussá, T. Baratelli, M. Martinez-Orellana, P. Ganges, L. Martínez, J. Bárcena, J. Montoya, M. Vaccine Article Virus-like particles (VLPs) have received considerable attention due to their potential application in veterinary vaccines and, in particular, VLPs from rabbit haemorrhagic disease virus (RHDV) have successfully shown to be good platforms for inducing immune responses against an inserted foreign epitope in mice. The aim of this study was to assess the immunogenicity of chimeric RHDV-VLPs as vaccine vectors in pigs. For this purpose, we have generated chimeric VLPs containing a well-known T epitope of 3A protein of foot-and-mouth disease virus (FMDV). Firstly, RHDV-VLPs were able to activate immature porcine bone marrow-derived dendritic cells (poBMDCs) in vitro. Secondly, pigs were inoculated twice in a two-week interval with chimeric RHDV-VLPs at different doses intranasally or intramuscularly. One intramuscularly treated group was also inoculated with adjuvant Montanide™ ISA 206 at the same time. Specific IgG and IgA antibodies against RHDV-VLPs were induced and such levels were higher in the adjuvanted group compared with other groups. Interestingly, anti-RHDV-VLP IgA responses were higher in groups inoculated intramuscularly than those that received the VLPs intranasally. Two weeks after the last immunisation, specific IFN-γ-secreting cells against 3A epitope and against RHDV-VLPs were detected in PBMCs by ELISPOT. The adjuvanted group exhibited the highest IFN-γ-secreting cell numbers and lymphoproliferative specific T cell responses against 3A epitope and RHDV-VLP. This is the first immunological report on the potential use of chimeric RHDV-VLPs as antigen carriers in pigs. Elsevier Ltd. 2012-03-23 2012-02-03 /pmc/articles/PMC7115503/ /pubmed/22306796 http://dx.doi.org/10.1016/j.vaccine.2012.01.069 Text en Copyright © 2012 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Crisci, E.
Fraile, L.
Moreno, N.
Blanco, E.
Cabezón, R.
Costa, C.
Mussá, T.
Baratelli, M.
Martinez-Orellana, P.
Ganges, L.
Martínez, J.
Bárcena, J.
Montoya, M.
Chimeric calicivirus-like particles elicit specific immune responses in pigs
title Chimeric calicivirus-like particles elicit specific immune responses in pigs
title_full Chimeric calicivirus-like particles elicit specific immune responses in pigs
title_fullStr Chimeric calicivirus-like particles elicit specific immune responses in pigs
title_full_unstemmed Chimeric calicivirus-like particles elicit specific immune responses in pigs
title_short Chimeric calicivirus-like particles elicit specific immune responses in pigs
title_sort chimeric calicivirus-like particles elicit specific immune responses in pigs
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115503/
https://www.ncbi.nlm.nih.gov/pubmed/22306796
http://dx.doi.org/10.1016/j.vaccine.2012.01.069
work_keys_str_mv AT criscie chimericcaliciviruslikeparticleselicitspecificimmuneresponsesinpigs
AT frailel chimericcaliciviruslikeparticleselicitspecificimmuneresponsesinpigs
AT morenon chimericcaliciviruslikeparticleselicitspecificimmuneresponsesinpigs
AT blancoe chimericcaliciviruslikeparticleselicitspecificimmuneresponsesinpigs
AT cabezonr chimericcaliciviruslikeparticleselicitspecificimmuneresponsesinpigs
AT costac chimericcaliciviruslikeparticleselicitspecificimmuneresponsesinpigs
AT mussat chimericcaliciviruslikeparticleselicitspecificimmuneresponsesinpigs
AT baratellim chimericcaliciviruslikeparticleselicitspecificimmuneresponsesinpigs
AT martinezorellanap chimericcaliciviruslikeparticleselicitspecificimmuneresponsesinpigs
AT gangesl chimericcaliciviruslikeparticleselicitspecificimmuneresponsesinpigs
AT martinezj chimericcaliciviruslikeparticleselicitspecificimmuneresponsesinpigs
AT barcenaj chimericcaliciviruslikeparticleselicitspecificimmuneresponsesinpigs
AT montoyam chimericcaliciviruslikeparticleselicitspecificimmuneresponsesinpigs